Table 4.
Cardiometabolic risk markers and lifestyle behaviors at baseline and 12 months post-intervention [M(SD)].
| Variable | N | Baseline | 12 months | Mean Change | 95% CI Lower, Upper | P value |
|---|---|---|---|---|---|---|
| Body mass (kg) | 11 | 99.0 (30.8) | 100.8 (31.2) | 1.86 (7.3) | −3.02, 6.7 | 0.42 |
| Body mass index (kg.m−2) | 11 | 33.0 (9.5) | 33.7 (9.9) | 0.7 (2.5) | −1.02, 2.3 | 0.41 |
| Waist circumference | 10 | 98.2 (21.0) | 99.7 (25.2) | 1.5 (8.0) | −4.3, 7.2 | 0.57 |
| Systolic blood pressure (mm Hg) | 11 | 121.6 (12.9) | 124.2 (15.7) | 2.5 (17.5) | −9.24, 14.3 | 0.64 |
| Diastolic blood pressure (mm Hg) | 11 | 80.9 (8.7) | 82.6 (6.7) | 1.7 (10.6) | −5.4, 8.9 | 0.60 |
| Resting heart rate (beats.min−1) | 10 | 86.8 (23.3) | 89.9 (22.2) | 3.1 (20.4) | −11.5, 17.7 | 0.64 |
| Total cholesterol (mmol.L−1) | 6 | 4.3 (0.9) | 4.1 (0.9) | −0.2 (0.9) | −1.2, 0.7 | 0.48 |
| HDL cholesterol (mmol.L−1) | 5 | 1.0 (0.2) | 1.6 (1.5) | 0.6 (1.5) | −1.2, 2.4 | 0.58 |
| Triglycerides (mmol.L−1) | 2 | 2.4 (2.2) | 2.9 (2.9) | 0.4 (1.5) | −5.7, 6.6 | 0.64 |
| HbA1C (mmol.mol) | 6 | 31.9 (14.6) | 37.7 (9.7) | 7.0 (11.4) | −5.6, 19.7 | 0.22 |
| Prolactin (mIU/L−1) | 4 | 1083.5 (707.3) | 433 (239.1) | −650.5 (595.3) | −1737.8, 436.8 | 0.15 |